Business Context and Reporting Period
Company: TherapeuticsMD, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: December 8, 2016
Purpose: Regulation FD Disclosure to furnish an investor presentation (Exhibit 99.1) intended for use at meetings with investors or analysts on December 8, 2016, and subsequently.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose the existence of an investor presentation and does not contain audited financial statements or specific financial data points.
Material Changes
No material changes to financial performance or operations are detailed in the text of this filing. The document references an attached presentation (Exhibit 99.1) which may contain such information, but the content of that presentation is not included in the provided text.
Guidance, Outlook, and Risks
Management Commentary: The company is furnishing an investor presentation dated December 2016.
Legal Status of Information: The information in this report and the attached exhibit is furnished pursuant to Item 7.01 and is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934. It is not subject to the liabilities of that section and will not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the content of Exhibit 99.1 (TherapeuticsMD, Inc. presentation dated December 2016) for specific financial data and strategic updates.
- Confirm that the presentation has not been modified since the filing date of December 8, 2016.
- Note that the information in this 8-K is not legally "filed" for liability purposes under Section 18 of the Exchange Act.